Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP-dependent protein disaggregase activity

CLPB HSPA1A HSPA1B

7.54e-0661463GO:0140545
GeneOntologyMolecularFunctiondenatured protein binding

HSPA1A HSPA1B

1.59e-0431462GO:0031249
GeneOntologyMolecularFunctionprotein-containing complex destabilizing activity

CLPB HSPA1A HSPA1B

1.63e-04151463GO:0140776
GeneOntologyMolecularFunctionmisfolded protein binding

DNAJB9 HSPA1A HSPA1B

2.88e-04181463GO:0051787
GeneOntologyCellularComponentCOP9 signalosome

NCKIPSD WDR6 HSPA1A HSPA1B

1.44e-04381474GO:0008180
HumanPhenoProgressive

KCTD7 CACNA1A VRK1 CAD HK1 DARS1 NDUFA13 AARS2 CLPB NALCN IGHMBP2 ALDH18A1 RARS2 MME COASY

4.99e-064304815HP:0003676
DomainG2F

HMCN2 HMCN1 NID1

1.90e-0641473PF07474
DomainNIDOGEN_G2

HMCN2 HMCN1 NID1

1.90e-0641473PS50993
DomainGFP

HMCN2 HMCN1 NID1

1.90e-0641473IPR009017
DomainG2_nidogen/fibulin_G2F

HMCN2 HMCN1 NID1

1.90e-0641473IPR006605
DomainBAF250/Osa

ARID1A ARID1B

6.15e-0521472IPR021906
DomainRSBN1

RSBN1 RSBN1L

6.15e-0521472IPR026306
DomainBAF250_C

ARID1A ARID1B

6.15e-0521472IPR033388
DomainBAF250_C

ARID1A ARID1B

6.15e-0521472PF12031
DomainGFP-like

STAB2 HMCN1 NID1

7.53e-05111473IPR023413
Domain-

STAB2 HMCN1 NID1

7.53e-051114732.40.155.10
DomainG2F

HMCN1 NID1

1.84e-0431472SM00682
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

IL12RB2 TCF12 UACA ENTR1 FBF1 BCL11A TUBGCP2 ARID1A RSBN1 PJA2 SETD2 ARID1B HMCN2 SUGP2 UBR5 WDR6 RARS2 RIC8A RSBN1L ZNF646

7.09e-0811161492031753913
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

CAD MYCBP2 TFIP11 ACTN1 MED1 ARID1A SETD2 ARID1B SUGP2 WDR6 PHACTR4 NCAPD2 PATJ RSBN1L

1.17e-075491491438280479
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ZFP90 FBF1 FNDC3A ANKRD50 TIAM2 GPR107 ARID1B NUAK1 INTS2 SYNJ2 NCAPD2 CPNE1 ZNF646

5.13e-075291491314621295
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

ENTR1 FBF1 NCKIPSD FRYL TUBGCP2 ARID1A RTKN ARID1B UBR5 ALDH18A1 PATJ PLOD1

5.56e-074461491224255178
Pubmed

Genetic linkage analysis of susceptibility to particle exposure in mice.

TPSD1 HSPA1A HSPA1B

7.66e-075149310783129
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

CAD HK1 MYCBP2 INTS1 FRYL ACTN1 ARID1A MDN1 SUGP2 UBR5 WDR6 NCAPD2 ALDH18A1 PLOD1

9.35e-076531491422586326
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

INTS1 TFIP11 TUBGCP2 MED1 ARID1A RSBN1 ARID1B EBP NCAPD2 RSBN1L

2.36e-063411491032971831
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

TCF12 INTS1 ARID1A SETD2 MDN1 SUGP2 INTS2 UBR5 NCAPD2

3.86e-06282149923667531
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

VRK1 CAD HK1 MYCBP2 INTS1 TFIP11 MED1 FLG2 ARID1A NDUFA13 SETD2 ARID1B NRXN1 SUGP2 EBP CPNE1 PLOD1

4.30e-0610821491738697112
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

TCF12 UACA MYCBP2 TUBGCP2 DNAJB9 RTKN CEP128 ZNF691 MDN1 SUGP2 INTS2 UBR5 IGHMBP2 PLOD1

4.93e-067541491433060197
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

SCFD2 CAD HK1 UACA MYCBP2 ENTR1 FNDC3A TFIP11 DNAJB9 PJA2 MDN1 CLPB UBR5 WDR6 PHACTR4 COASY HSPA1A PLOD1 HSPA1B VPS13B

6.01e-0614871492033957083
Pubmed

Characterization of the human COP9 signalosome complex using affinity purification and mass spectrometry.

NCKIPSD WDR6 HSPA1A HSPA1B

1.06e-0532149418850735
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

ZFP90 INTS1 ZNF813 FNDC3A TFIP11 ACTN1 ZNF581 ZNF691 RSBN1 ARID1B ZNF28 FADS3 INTS2 EBP NCAPD2 PLOD1 ZNF646

1.70e-0512031491729180619
Pubmed

Exercise induces hepatosplanchnic release of heat shock protein 72 in humans.

HSPA1A HSPA1B

1.82e-052149212411538
Pubmed

Molecular cloning and analysis of DNA complementary to three mouse Mr = 68,000 heat shock protein mRNAs.

HSPA1A HSPA1B

1.82e-05214922868009
Pubmed

Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients.

HSPA1A HSPA1B

1.82e-052149224328534
Pubmed

In vitro transcription of a human hsp 70 heat shock gene by extracts prepared from heat-shocked and non-heat-shocked human cells.

HSPA1A HSPA1B

1.82e-05214923786141
Pubmed

Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis.

KIR2DL1 KIR2DS1

1.82e-052149229384924
Pubmed

Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides.

HSPA1A HSPA1B

1.82e-052149226923070
Pubmed

Surface expression of HSP72 by LPS-stimulated neutrophils facilitates gammadeltaT cell-mediated killing.

HSPA1A HSPA1B

1.82e-052149216482515
Pubmed

Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72.

HSPA1A HSPA1B

1.82e-052149211864979
Pubmed

Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice.

MMEL1 MME

1.82e-052149229191928
Pubmed

Hippocampal 72-kDa heat shock protein expression varies according to mice learning performance independently from chronic exposure to stress.

HSPA1A HSPA1B

1.82e-052149215719414
Pubmed

Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk.

HSPA1A HSPA1B

1.82e-052149226976620
Pubmed

Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.

KIR2DL1 KIR2DS1

1.82e-052149216141329
Pubmed

Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody.

HSPA1A HSPA1B

1.82e-052149221187371
Pubmed

Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer.

HSPA1A HSPA1B

1.82e-052149220430459
Pubmed

Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia.

HSPA1A HSPA1B

1.82e-052149220235222
Pubmed

Genetic determinants of HSP70 gene expression following heat shock.

HSPA1A HSPA1B

1.82e-052149220876613
Pubmed

The C-terminal BAG domain of BAG5 induces conformational changes of the Hsp70 nucleotide-binding domain for ADP-ATP exchange.

HSPA1A HSPA1B

1.82e-052149220223214
Pubmed

Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

HSPA1A HSPA1B

1.82e-052149220093776
Pubmed

Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells.

HSPA1A HSPA1B

1.82e-052149223704948
Pubmed

Structure and expression of the human gene encoding major heat shock protein HSP70.

HSPA1A HSPA1B

1.82e-05214922858050
Pubmed

Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release.

HSPA1A HSPA1B

1.82e-052149217513788
Pubmed

IL-6 activates HSP72 gene expression in human skeletal muscle.

HSPA1A HSPA1B

1.82e-052149212207910
Pubmed

Inducing heat shock protein 70 expression provides a robust antithrombotic effect with minimal bleeding risk.

HSPA1A HSPA1B

1.82e-052149228837204
Pubmed

Concurrent action of purifying selection and gene conversion results in extreme conservation of the major stress-inducible Hsp70 genes in mammals.

HSPA1A HSPA1B

1.82e-052149229572464
Pubmed

Protective effect of heat shock proteins 70.1 and 70.3 on retinal photic injury after systemic hyperthermia.

HSPA1A HSPA1B

1.82e-052149215988927
Pubmed

Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.

ARID1A ARID1B

1.82e-052149237611161
Pubmed

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.

ARID1A ARID1B

1.82e-052149232791957
Pubmed

Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.

HSPA1A HSPA1B

1.82e-052149226448330
Pubmed

HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts.

HSPA1A HSPA1B

1.82e-052149212714332
Pubmed

Inflammation-induced, 3'UTR-dependent translational inhibition of Hsp70 mRNA impairs intestinal homeostasis.

HSPA1A HSPA1B

1.82e-052149219299581
Pubmed

The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling.

KIR2DL1 KIR2DS1

1.82e-052149227210755
Pubmed

Insights into regulation and function of the major stress-induced hsp70 molecular chaperone in vivo: analysis of mice with targeted gene disruption of the hsp70.1 or hsp70.3 gene.

HSPA1A HSPA1B

1.82e-052149211713291
Pubmed

Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice.

HSPA1A HSPA1B

1.82e-052149221108992
Pubmed

Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).

HSPA1A HSPA1B

1.82e-052149231320473
Pubmed

KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity.

KIR2DL1 KIR2DS1

1.82e-052149238240527
Pubmed

Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.

ARID1A ARID1B

1.82e-052149228967863
Pubmed

hsp72, a host determinant of measles virus neurovirulence.

HSPA1A HSPA1B

1.82e-052149216971451
Pubmed

In silico based investigation of dynamic variations in neprilysin (NEP and NEP2) proteins for extracting the point of specificity.

MMEL1 MME

1.82e-052149226846903
Pubmed

Heat shock protein 70 promotes lipogenesis in HepG2 cells.

HSPA1A HSPA1B

1.82e-052149229631603
Pubmed

Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation.

HSPA1A HSPA1B

1.82e-052149221757701
Pubmed

Role of membrane Hsp70 in radiation sensitivity of tumor cells.

HSPA1A HSPA1B

1.82e-052149226197988
Pubmed

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation.

FLT3 LCK

1.82e-052149229062038
Pubmed

Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis.

HSPA1A HSPA1B

1.82e-052149222792201
Pubmed

Inhibition of hsp70-1 and hsp70-3 expression disrupts preimplantation embryogenesis and heightens embryo sensitivity to arsenic.

HSPA1A HSPA1B

1.82e-05214929820195
Pubmed

Surface expression of a C-terminal alpha-helix region in heat shock protein 72 on murine LL/2 lung carcinoma can be recognized by innate immune sentinels.

HSPA1A HSPA1B

1.82e-052149219157555
Pubmed

Heat Shock Protein 70 Is Involved in the Efficiency of Preconditioning with Cyclosporine A in Renal Ischemia Reperfusion Injury by Modulating Mitochondrial Functions.

HSPA1A HSPA1B

1.82e-052149237298493
Pubmed

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.

BCL11A MIPEP

1.82e-052149234706496
Pubmed

Genetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistance.

HSPA1A HSPA1B

1.82e-052149225618331
Pubmed

Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.

ARID1A ARID1B

1.82e-052149234386776
Pubmed

Human neprilysin-2 (NEP2) and NEP display distinct subcellular localisations and substrate preferences.

MMEL1 MME

1.82e-052149218539150
Pubmed

Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury.

HSPA1A HSPA1B

1.82e-052149216679378
Pubmed

Inducible 70 kDa heat shock proteins protect embryos from teratogen-induced exencephaly: Analysis using Hspa1a/a1b knockout mice.

HSPA1A HSPA1B

1.82e-052149219639652
Pubmed

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.

ARID1A ARID1B

1.82e-052149223202128
Pubmed

Effect of mutation of amino acids 246-251 (KRKHKK) in HSP72 on protein synthesis and recovery from hypoxic injury.

HSPA1A HSPA1B

1.82e-052149216100242
Pubmed

Role of the C-terminal region of mouse inducible Hsp72 in the recognition of peptide substrate for chaperone activity.

HSPA1A HSPA1B

1.82e-052149215498567
Pubmed

Biological activity of truncated C-terminus human heat shock protein 72.

HSPA1A HSPA1B

1.82e-052149221094186
Pubmed

ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.

ARID1A ARID1B

1.82e-052149233890484
Pubmed

Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells.

HSPA1A HSPA1B

1.82e-052149217482577
Pubmed

Structure and expression of an inducible HSP70-encoding gene from Mus musculus.

HSPA1A HSPA1B

1.82e-05214928076831
Pubmed

The 70 kDa heat shock protein protects against experimental traumatic brain injury.

HSPA1A HSPA1B

1.82e-052149223816752
Pubmed

ARID1B is a specific vulnerability in ARID1A-mutant cancers.

ARID1A ARID1B

1.82e-052149224562383
Pubmed

Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.

HMCN2 HMCN1

1.82e-052149232035013
Pubmed

Structure of a new crystal form of human Hsp70 ATPase domain.

HSPA1A HSPA1B

1.82e-052149210216320
Pubmed

Effects of voluntary exercise and genetic selection for high activity levels on HSP72 expression in house mice.

HSPA1A HSPA1B

1.82e-052149214672969
Pubmed

Genetic Modulation of HSPA1A Accelerates Kindling Progression and Exerts Pro-convulsant Effects.

HSPA1A HSPA1B

1.82e-052149229964156
Pubmed

Molecular cloning of sequences encoding the human heat-shock proteins and their expression during hyperthermia.

HSPA1A HSPA1B

1.82e-05214923019832
Pubmed

Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population.

HSPA1A HSPA1B

1.82e-052149217364813
Pubmed

Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance.

HSPA1A HSPA1B

1.82e-052149224430435
Pubmed

Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse.

HSPA1A HSPA1B

1.82e-052149222940431
Pubmed

The role of heat shock protein 70 in mediating age-dependent mortality in sepsis.

HSPA1A HSPA1B

1.82e-052149221296977
Pubmed

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.

ARID1A ARID1B

1.82e-052149229890703
Pubmed

The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages.

HSPA1A HSPA1B

1.82e-052149217617616
Pubmed

Downregulation of Heat Shock Protein 70 Impairs Osteogenic and Chondrogenic Differentiation in Human Mesenchymal Stem Cells.

HSPA1A HSPA1B

1.82e-052149229323151
Pubmed

The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B.

HSPA1A HSPA1B

1.82e-052149215232679
Pubmed

Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors.

HSPA1A HSPA1B

1.82e-052149238703814
Pubmed

Structure and function of Hip, an attenuator of the Hsp70 chaperone cycle.

HSPA1A HSPA1B

1.82e-052149223812373
Pubmed

Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington's disease.

HSPA1A HSPA1B

1.82e-052149219605647
Pubmed

SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.

ARID1A ARID1B

1.82e-052149224788099
Pubmed

Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1.

KIR2DL1 KIR2DS1

1.82e-052149218643963
Pubmed

Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.

ARID1A ARID1B

1.82e-052149233052929
Pubmed

Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation.

HSPA1A HSPA1B

1.82e-052149221970979
Pubmed

Induction of heat shock protein 70 inhibits ischemic renal injury.

HSPA1A HSPA1B

1.82e-052149221270764
Pubmed

[Relationship between heat stress protein 70 gene polymorphisms and the risk of acute mountain sickness].

HSPA1A HSPA1B

1.82e-052149215748471
Pubmed

Heat shock protein 70 upregulation by geldanamycin reduces brain injury in a mouse model of intracerebral hemorrhage.

HSPA1A HSPA1B

1.82e-052149220849898
Pubmed

Carbonic anhydrase-related protein CA10 is an evolutionarily conserved pan-neurexin ligand.

CA10 NRXN1

1.82e-052149228154140
Pubmed

Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer.

HSPA1A HSPA1B

1.82e-052149219005184
Pubmed

The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.

BCL11A MIPEP

1.82e-052149227838552
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZFP90 ZNF484 ZNF813 ZNF213 BCL11A ZNF581 ZNF229 ZNF691 ZIC1 ZNF28 ZNF799 ZNF860 ZNF646

1.79e-047181011328
GeneFamilyFibulins

HMCN2 HMCN1

8.46e-0481012556
GeneFamilyMannosyl-glycoprotein N-acetylglucosaminyltransferases

MGAT4C MGAT5B

1.08e-0391012435
GeneFamilyPDZ domain containing

PREX2 TIAM2 LRRC7 PATJ SNTA1

1.63e-0315210151220
GeneFamilyHAD Asp-based non-protein phosphatases

ENOPH1 PHOSPHO1

1.64e-031110121045
GeneFamilyAT-rich interaction domain containing

ARID1A ARID1B

3.09e-03151012418
GeneFamilyIntegrator complex

INTS1 INTS2

3.09e-031510121366
GeneFamilyCadherin related

CDHR3 CLSTN1

3.98e-0317101224
GeneFamilyHeat shock 70kDa proteins

HSPA1A HSPA1B

3.98e-03171012583
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL1 KIR2DS1

4.46e-03181012620
GeneFamilyAminoacyl tRNA synthetases, Class II

DARS1 AARS2

4.97e-03191012132
GeneFamilyG-patch domain containing|Minor histocompatibility antigens

TFIP11 SUGP2

6.64e-03221012579
GeneFamilyAbhydrolase domain containing

ABHD17A ABHD17B

6.64e-032210124
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MAGEL2 GABRQ CHRNA2 ADCY7 WDR6 CNTNAP4 MGAT4C

9.75e-071571487741d79c10cb87fa7f14080c6fccb1553c3a20bad
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1A CSMD2 NRXN1 CNTNAP4 MME TMC5 PATJ

1.47e-0616714873edb0570e583bb527165bcd8a4c25a042054043b
ToppCell10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

IL12RB2 FLT3 MYCBP2 BCL11A LCK NIBAN3 GGT5

3.23e-0618814870a47de24812c619f6756c9351a413b109128d54f
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCP SORT1 PIK3C2G ATP6V0A4 TMC5 PATJ FAM20A

3.59e-0619114873e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCellImmune-natural_killer_cell|World / Lineage, Cell type, age group and donor

ABHD17A IL12RB2 LCK CD160 CD69 LGR6 KIR2DL1

3.72e-06192148768121a6ef4115a93d87aad8802ef9b27d793d8c0
ToppCellControl-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class

UACA RYR2 SORT1 HMCN1 NUAK1 NALCN MME

3.85e-0619314875896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCP SORT1 PIK3C2G ATP6V0A4 TMC5 PATJ FAM20A

3.98e-06194148704bfc555743f7d8821439d05ae442d15e9886c59
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CACNA1A ACTN1 FLG2 CSMD2 HMCN2 HMCN1 MME

4.12e-061951487d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CACNA1A ACTN1 FLG2 CSMD2 HMCN2 HMCN1 MME

4.12e-06195148719853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IL12RB2 LCK MMEL1 CD69 HSPA1A IL4I1 HSPA1B

4.55e-06198148790863377ed36afc30bc1a068612ad1adc77af5a8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NCKIPSD ZNF813 LCK MIPEP CD69 CNDP1

6.60e-0613714860c82f815c014d01213d23b466043d6e57186dceb
ToppCell3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue

LCK FLG2 CA10 CD69 IL4I1 SNTA1

1.34e-05155148672c61be0a8d3ee10600a33c58fb01c35fd3f14d4
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TMPRSS9 FBF1 CEP128 CHRNA2 PHOSPHO1 FAM9C

1.44e-0515714864766f7d545bf2d775390589460677519cb92f4d5
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCP RYR2 HMCN1 PIK3C2G CNTNAP4 MME

1.60e-051601486c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCP RYR2 HMCN1 PIK3C2G CNTNAP4 MME

1.60e-05160148625c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZNF484 KCP FRYL ACTN1 ZNF799 PATJ

1.66e-0516114865fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCellMild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

CACNA1A GGT5 FAM20A HSPA1A IL4I1 HSPA1B

1.72e-051621486e5fc80ab19d513af6a7e677a5e67bfebca2e963b
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type

CACNA1A RBPJL RYR2 NRXN1 CNTNAP4 MGAT4C

1.78e-05163148619c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCellsevere-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CARMIL2 BCL11A ZNF229 NIBAN3 FADS3 CD69

1.84e-051641486a1031e9f945a15186ee14c12be47aa11c3c6583b
ToppCell3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IL12RB2 CARMIL2 FBF1 CA10 CD160 CD69

1.90e-0516514869f6f3a614ac614488e9f59cf2805467ff075ccca
ToppCelldroplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL12RB2 FRYL LCK ABHD17B LGR6 ZNF646

2.04e-051671486a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IL12RB2 LCK CD160 CD69 KIR2DL1 HSPA1A

2.11e-051681486696b31bedbc7d40817a733e8c6ec2633404be619
ToppCelldroplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL12RB2 FLT3 BCL11A CEP128 FADS3 CD69

2.41e-05172148624ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCelldroplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL12RB2 FLT3 BCL11A CEP128 FADS3 CD69

2.41e-051721486db5a31cafce4346fe459d7f35210823fd7004439
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SCFD2 CDHR3 LCK CD160 SETD2 AARS2

2.49e-051731486b6bb2a136a40f0946bbcde8d5972d3f059d080c7
ToppCelldroplet-Large_Intestine-COLON_-_"PROM_Tm"|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMGCS2 DNAJB9 PHOSPHO1 HSPA1A HSPA1B MGAT4C

2.74e-0517614863c3b6c02d7acdc1305878ee34e9cbabbf9e87892
ToppCelldroplet-Large_Intestine-COLON_-_"PROM_Tm"-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMGCS2 DNAJB9 PHOSPHO1 HSPA1A HSPA1B MGAT4C

2.74e-0517614867c743b7e954c1ebfa289ed529abacb88504112ea
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

STAB2 CD160 C10orf62 CNDP1

2.90e-055314845fa009c9f30c77de6cece40a47da46241f1de54c
ToppCellPosterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Egln3_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

STAB2 CD160 C10orf62 CNDP1

2.90e-0553148452a1f2a041e3ba2b11ed753f2f57b78e68b5cc0c
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

STAB2 GGT5 FADS3 NID1 HSPA1A MGAT4C

3.20e-051811486e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCellGlobus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

FLT3 MAGEL2 YPEL4 MMEL1 CNTNAP4 MME

3.30e-05182148604ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CARMIL2 BCL11A LCK RBM48 CD69 PATJ

3.41e-051831486a305667cfdae50e64e1890f10f71b407ae617b80
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 RYR2 HMCN1 NRXN1 PIK3C2G CNTNAP4

3.51e-0518414862cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 RYR2 HMCN1 NRXN1 PIK3C2G CNTNAP4

3.51e-051841486ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAB2 RYR2 HMCN1 NRXN1 PIK3C2G CNTNAP4

3.51e-0518414862b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellsevere_influenza-RBC|World / disease group, cell group and cell class (v2)

TMPRSS9 YPEL4 PHOSPHO1 HSPA1A HSPA1B DYRK3

3.84e-051871486f846750575f318503d21ade30f5bfd2e1d4c84af
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA6B FLT3 ACTN1 ACOX2 NRXN1 NID1

3.84e-0518714863b1439018e265a61d9599e307a202e3c2f60ed32
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA6B FLT3 ACTN1 ACOX2 NRXN1 NID1

3.84e-051871486e99bc27d212c74da37770297122a4b30445ccd0d
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN1 CA10 HMCN1 PIK3C2G ATP6V0A4 PATJ

3.84e-051871486f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UACA RYR2 HMCN1 UBR5 PHACTR4 RARS2

3.96e-0518814866468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UACA RYR2 HMCN1 UBR5 PHACTR4 RARS2

3.96e-0518814867a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

UACA RYR2 HMCN1 UBR5 PHACTR4 RARS2

3.96e-0518814869cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellInfluenza_Severe-RBC|World / Disease group and Cell class

TMPRSS9 YPEL4 PHOSPHO1 HSPA1A HSPA1B DYRK3

3.96e-051881486f0438e6a77ee1f0456cb65926685266fff470983
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ABHD17A IL12RB2 LCK CD160 CD69 KIR2DL1

4.08e-051891486c604da558c9f4055fb36218452463539f2a73223
ToppCellLPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KCP HMGCS2 CSMD2 NRXN1 ENDOU

4.13e-051151485ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCellLPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KCP HMGCS2 CSMD2 NRXN1 ENDOU

4.13e-0511514857a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCellLPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KCP HMGCS2 CSMD2 NRXN1 ENDOU

4.13e-051151485c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN1 RYR2 HMCN2 NALCN NID1 LRRC7

4.20e-0519014862e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCellPCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

IL12RB2 LCK CD160 CD69 KIR2DL1 IL4I1

4.20e-0519014865c6801046ab88aad76697984342319872a8f9e38
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN1 RYR2 HMCN2 NALCN NID1 LRRC7

4.20e-0519014860028f886c789ba238c031eae5d96acaed4af8c25
ToppCell(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class

SEMA6B STAB2 PREX2 HSPA1A PLOD1 HSPA1B

4.20e-051901486ff083168d609957d00888f31b3488d6d56c902b4
ToppCellsevere-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

IL12RB2 CDHR3 PHTF2 LCK ADPRH NALCN

4.32e-051911486afff6bfae9a2f1e17d2731315e7fe63c4601679f
ToppCellFetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ABHD17A IL12RB2 LCK CD160 CD69 KIR2DL1

4.32e-0519114865696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF12 NIBAN3 ARID1B NUAK1 CD69 ENDOU

4.32e-051911486318323a12029a7992f16382cb0c186f5b2e1ca47
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD17A FLT3 BCL11A FADS3 ABHD17B COASY

4.32e-0519114864187f31ec399b4c7c3608e94e3c32b7a54b1c3d4
ToppCelldroplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD17A FLT3 BCL11A FADS3 ABHD17B COASY

4.32e-0519114868e8bc200524a44ebe132f823ab7c15dac65d4952
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABHD17A IL12RB2 LCK CD160 CD69 LGR6

4.32e-0519114866345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF12 NIBAN3 ARID1B NUAK1 CD69 ENDOU

4.32e-0519114864aa29337f4d2528577bb90dc4abfb6eab93e120f
ToppCellTracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

LCK ADCY7 CD160 CD69 KIR2DL1 FAM9C

4.58e-05193148691a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PRTG FLT3 KCP BCL11A FAM20A MGAT4C

4.58e-051931486e74fdc8718fe0933e1f4dd3fe37e2134983b99b6
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABHD17A IL12RB2 LCK CD160 LGR6 KIR2DL1

4.58e-0519314861cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCelldistal-Hematologic-CD4+_Memory/Effector_T-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

FLT3 LCK CEP128 TIAM2 CD69 ZNF860

4.58e-05193148658651c32820f268098d8979937397786d18bd0a1
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PRTG FLT3 KCP BCL11A FAM20A MGAT4C

4.58e-051931486658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACTN1 PREX2 GGT5 HMCN1 NUAK1 IL4I1

4.58e-0519314867261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCellCOVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type

ABHD17A IL12RB2 LCK ADCY7 CD69 LGR6

4.58e-051931486c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCellCOVID-19_Moderate-B_naive|COVID-19_Moderate / disease group, cell group and cell class

BCL11A NIBAN3 FADS3 CD69 ZNF860 MME

4.72e-0519414868c41a37467bfd4966ecd09dde68c543dc01b6ad0
ToppCellCOVID-19_Moderate-B_naive|World / disease group, cell group and cell class

BCL11A NIBAN3 FADS3 CD69 ZNF860 MME

4.72e-0519414861f81d618799e482a36dce528bba70f52cc69a901
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KCP SORT1 PIK3C2G ATP6V0A4 TMC5 FAM20A

4.72e-05194148669bff17df4a760ccf081cf52ff04af02c14f448d
ToppCellwk_15-18-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ABHD17A IL12RB2 LCK CD160 CD69 KIR2DL1

4.72e-05194148654c809ed134ed828f3653603cf821cc303240f36
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PRTG FLT3 KCP BCL11A FAM20A MGAT4C

4.72e-0519414861bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

ABHD17A LCK CD160 CD69 LGR6 KIR2DL1

4.85e-051951486e91e7f89163c615b706f3297b641b1e4c966f5e6
ToppCell10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

UACA ACTN1 GGT5 NCAPD2 NID1 MME

4.85e-05195148678cfde21dde4b877fc76c8b0d5ddaabe44b912d7
ToppCell390C|World / Donor, Lineage, Cell class and subclass (all cells)

LCK DNAJB9 TPSD1 CD69 HSPA1A HSPA1B

4.85e-051951486b955e83c2bf7a7e20ee50fab9dc9678f36d5bfd6
ToppCellCOPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class

IL12RB2 LCK RYR2 RSBN1 SYNJ2 CD69

4.99e-05196148630e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN1 RYR2 HMCN2 NALCN NID1 LRRC7

4.99e-0519614861522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN1 RYR2 HMCN2 NALCN NID1 LRRC7

4.99e-0519614861c8294014713684b50885e638668f2ce75f357f0
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

DNAJB9 CD160 ABHD17B CD69 HSPA1A HSPA1B

5.14e-051971486cd54e6ad175529327fa0372033016b3b978dd452
ToppCellLPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FLT3 BCL11A NIBAN3 ADCY7 HSPA1B DYRK3

5.14e-0519714868fa38fb95e285f9cc756ec4f32009be4ede09d3c
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

UACA CDHR3 RYR2 HMCN1 NALCN NID1

5.14e-0519714866d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DNAJB9 CD160 ABHD17B CD69 HSPA1A HSPA1B

5.28e-051981486294a48ef6c0b89c7be948452cea79d23d3901e75
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

BCL11A TIAM2 NRXN1 LRRC7 HSPA1A RSBN1L

5.28e-051981486de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCellMS-IIF-Lymphocyte-T/NK-gd_T|IIF / Disease, condition lineage and cell class

ABHD17A IL12RB2 LCK CD160 NUAK1 CD69

5.43e-0519914862c0e981839c256d76fa049532c8d49f31ce9bfee
ToppCellMacroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-0520014864dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IL12RB2 LCK CD160 CD69 LGR6 KIR2DL1

5.58e-0520014860b65855617fb7730de48facf411e2a8980f9f780
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

UACA RYR2 HMCN1 NUAK1 NID1 MME

5.58e-052001486e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

KCP ACTN1 ANKRD50 RYR2 SYNJ2 NID1

5.58e-0520014864e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCellMacroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-05200148626b989e30bbbaf30904ced03f6aae3dea25c732c
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IL12RB2 LCK CD160 CD69 LGR6 KIR2DL1

5.58e-0520014864150170a135c37a7932bfb61acedac22dad01a3e
ToppCellBiopsy_Other_PF-Immune-NK_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type

IL12RB2 LCK CD160 CD69 LGR6 KIR2DL1

5.58e-052001486418d665b8431697fc9e516258c9fe374257750d9
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IL12RB2 LCK CD160 CD69 LGR6 KIR2DL1

5.58e-0520014860a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

KCP ACTN1 ANKRD50 RYR2 SYNJ2 NID1

5.58e-052001486786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCellMacroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-0520014861314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCellMacroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-0520014868b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCellsevere-B_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

UACA BCL11A NIBAN3 FADS3 CD69 ZNF860

5.58e-052001486306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCellMacroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-052001486272909f4354f3ae22e2b2f8f35970e6b0e92cfe2
ToppCellMacroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic

FRYL SORT1 RNF220 SYNJ2 CNTNAP4 CNDP1

5.58e-0520014865f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FLT3 UROC1 CNTNAP4 MME PLOD1

8.85e-05135148554b2aaf8d322e01a3ff6099c2422d68ecccf96b4
ToppCellsevere-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

UACA BCL11A ZNF229 NIBAN3 FADS3

9.16e-05136148556a7b5c2e098b4a49124d1b905257a52eb38b519
ToppCellsevere_COVID-19-gd_T|World / disease group, cell group and cell class (v2)

TRPA1 LCK CD160 CD69 KIR2DL1

1.09e-041411485d2575900775ce6801364c2d4eed8d213f30fa0e0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KCP MMEL1 LGR6 TMC5 FAM20A

1.09e-041411485091b5b72811db5fca2314f4a79d467566920e257
Diseasehypothyroidism

IL12RB2 FLT3 FNDC3A CEP128 ADCY7 RSBN1 CD69 RSBN1L

7.73e-052841438EFO_0004705
DiseasePlagiocephaly

TCF12 ZIC1

1.39e-0441432C0265529
Diseasegraft-versus-host disease (biomarker_via_orthology)

HSPA1A HSPA1B

2.31e-0451432DOID:0081267 (biomarker_via_orthology)
DiseaseMENTAL RETARDATION, AUTOSOMAL DOMINANT 12

ARID1A ARID1B

2.31e-0451432C3281201
DiseaseKlatskin's tumor (is_implicated_in)

ARID1A PREX2

2.31e-0451432DOID:4927 (is_implicated_in)
DiseaseAtaxia

CACNA1A HK1 UROC1

2.37e-04251433C0004134
DiseasePontocerebellar Hypoplasia Type 1

VRK1 RARS2

3.45e-0461432C1843504
Diseasebrain disease (implicated_via_orthology)

MYCBP2 TIAM2

3.45e-0461432DOID:936 (implicated_via_orthology)
Diseasecerebellar ataxia (implicated_via_orthology)

CACNA1A AARS2

6.41e-0481432DOID:0050753 (implicated_via_orthology)
DiseaseEmbryonal Rhabdomyosarcoma

ARID1A SETD2

6.41e-0481432C0206656
Diseasedrug dependence

NRXN1 SYNJ2 MGAT5B

6.51e-04351433EFO_0003890
DiseaseMajor depression, single episode

HSPA1A HSPA1B

8.21e-0491432C0024517
Diseaseneuroblastoma (is_implicated_in)

ARID1A ARID1B

1.02e-03101432DOID:769 (is_implicated_in)
DiseaseCharcot-Marie-Tooth disease

HK1 IGHMBP2 MME

1.11e-03421433cv:C0007959
DiseaseSemantic-Pragmatic Disorder

BCL11A NRXN1

1.25e-03111432C0454655
Diseasecell growth regulator with EF hand domain protein 1 measurement

CPNE1 NID1

1.25e-03111432EFO_0801461
DiseaseAuditory Processing Disorder, Central

BCL11A NRXN1

1.25e-03111432C0751257
DiseaseLanguage Delay

BCL11A NRXN1

1.25e-03111432C0023012
DiseaseLanguage Development Disorders

BCL11A NRXN1

1.25e-03111432C0023014
DiseaseSpeech Delay

BCL11A NRXN1

1.25e-03111432C0241210
Diseasecraniosynostosis (is_implicated_in)

TCF12 ZIC1

1.49e-03121432DOID:2340 (is_implicated_in)
DiseaseCoffin-Siris syndrome

ARID1A ARID1B

1.76e-03131432C0265338
DiseaseCongenital pontocerebellar hypoplasia

VRK1 RARS2

1.76e-03131432C0266468
Diseaseearly cardiac repolarization measurement

MYCBP2 MGAT5B

2.04e-03141432EFO_0004885
Diseaseeating disorder, bipolar disorder

RYR2 NALCN

2.04e-03141432EFO_0005203, MONDO_0004985
DiseaseMalignant neoplasm of breast

BCL11A ARID1A SETD2 ARID1B SYNJ2 RIC8A LRRC7 MME LGR6 PLOD1 HSPA1B VPS13B ZNF646

2.24e-03107414313C0006142
DiseaseDown syndrome (implicated_via_orthology)

SYNJ2 DYRK3

2.35e-03151432DOID:14250 (implicated_via_orthology)
DiseaseReplication Error Phenotype

ARID1A SETD2

2.35e-03151432C1721098
DiseaseMicrosatellite Instability

ARID1A SETD2

2.35e-03151432C0920269
Diseasealcohol use disorder (implicated_via_orthology)

ARID1A CHRNA2 RYR2 ARID1B FADS3

2.66e-031951435DOID:1574 (implicated_via_orthology)
DiseaseTremor, Rubral

CACNA1A UROC1

2.68e-03161432C0750940
DiseaseAtaxia, Appendicular

CACNA1A UROC1

2.68e-03161432C0750937
DiseaseAtaxia, Motor

CACNA1A UROC1

2.68e-03161432C0278161
DiseaseSynostotic Posterior Plagiocephaly

TCF12 ZIC1

2.68e-03161432C1833340
DiseaseAtaxia, Sensory

CACNA1A UROC1

2.68e-03161432C0240991
DiseaseCraniosynostosis, Type 1

TCF12 ZIC1

2.68e-03161432C4551902
DiseaseAcrocephaly

TCF12 ZIC1

2.68e-03161432C0030044
DiseaseAbnormal coordination

CACNA1A UROC1

2.68e-03161432C0520966
DiseaseTrigonocephaly

TCF12 ZIC1

2.68e-03161432C0265535
DiseaseScaphycephaly

TCF12 ZIC1

2.68e-03161432C0265534
DiseaseAtaxia, Truncal

CACNA1A UROC1

2.68e-03161432C0427190
DiseaseSynostotic Anterior Plagiocephaly

TCF12 ZIC1

2.68e-03161432C2931150
DiseasePontoneocerebellar hypoplasia

VRK1 RARS2

2.68e-03161432cv:C1261175
DiseaseMetopic synostosis

TCF12 ZIC1

2.68e-03161432C1860819
DiseaseBrachycephaly

TCF12 ZIC1

3.02e-03171432C0221356
DiseaseCharcot-Marie-Tooth disease type 2

IGHMBP2 MME

3.02e-03171432cv:C0270914
Diseasephosphatidylcholine 36:4 measurement

VRK1 FADS3

3.39e-03181432EFO_0010382
Diseaserheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement

FLT3 KCP RSBN1

3.58e-03631433EFO_0000685, EFO_0007791, EFO_0009459
Diseaseanorectal malformation

UROC1 CSMD2

3.78e-03191432MONDO_0019938
DiseaseCannabis use, age at onset

RYR2 LRRC7

3.78e-03191432EFO_0004847, EFO_0007585
Diseaselevel of Sterol ester (27:1/20:3) in blood serum

FADS3 NRXN1

3.78e-03191432OBA_2045199
Diseasesclerosing cholangitis

KCP MMEL1 MME

4.08e-03661433EFO_0004268
DiseaseCraniosynostosis

TCF12 ZIC1

4.18e-03201432C0010278
Diseasecitrulline measurement

HMCN2 ALDH18A1

4.18e-03201432EFO_0009777
DiseaseX-24309 measurement

FBF1 CHRNA2

4.18e-03201432EFO_0800872
Diseasehearing loss

TMPRSS9 SYNJ2 IL4I1

4.26e-03671433EFO_0004238
Diseasefetal hemoglobin measurement

BCL11A ATP6V0A4

4.61e-03211432EFO_0004576
Diseasesusceptibility to mononucleosis measurement

ANKRD50 RYR2 MDN1

4.62e-03691433EFO_0008403
DiseaseProfound Mental Retardation

VRK1 UROC1 NRXN1 CNDP1

4.75e-031391434C0020796
DiseaseMental Retardation, Psychosocial

VRK1 UROC1 NRXN1 CNDP1

4.75e-031391434C0025363
DiseaseMental deficiency

VRK1 UROC1 NRXN1 CNDP1

4.75e-031391434C0917816
DiseaseBreast Carcinoma

ARID1A SETD2 ARID1B SYNJ2 RIC8A MME LGR6 HSPA1B

4.83e-035381438C0678222

Protein segments in the cluster

PeptideGeneStartEntry
SDHHAREGSLEQPGF

CACNA1A

901

O00555
IHGILTNSGDFLHDA

ACOX2

581

Q99424
ASDLDGGTGSELHHF

CEP128

111

Q6ZU80
DRTFLEGSHTRGLDH

CEP128

1026

Q6ZU80
NHFDRDHSGTLGPEE

ACTN1

756

P12814
GHVARLEFQTDHSTG

CSMD2

661

Q7Z408
RQHLEFSHNEGTLSS

CD160

146

O95971
RHFSLGDFSHLGSRD

CARMIL2

191

Q6F5E8
THSFADHSGTIDDRE

CNTNAP4

1216

Q9C0A0
QGGSHTETEDRLFKH

CHRNA2

51

Q15822
HGTEDEVIDFSHGLA

ABHD17A

251

Q96GS6
LGGGDTTEHIQTHFE

ARID1B

1891

Q8NFD5
SRGADLEIEDAHGHT

ANKRD50

566

Q9ULJ7
HHFARAASEFESSEG

CLSTN1

661

O94985
PFAHLNHRESVSSGE

ADCY7

496

P51828
DGGSSRQRHHFQEFS

DNAJB9

146

Q9UBS3
GGDVATLELHGENFH

RBPJL

396

Q9UBG7
GELGSLFDHHVQRAV

RBM48

6

Q5RL73
GSRIESHHFAQADLE

GPR107

451

Q5VW38
GKHHGADDSRFSILA

PIK3C2G

131

O75747
QHQGHFGDDDVTLGS

NIBAN3

251

Q86XR2
SDVFDGISHEHHGRT

KIAA1107

956

Q9UPP5
IGGGDTTEHIQTHFE

ARID1A

1846

O14497
ENDATSPHFSTRHEG

CD69

21

Q07108
TGTEDRQNDILHHGA

MGAT4C

396

Q9UBM8
GSQHGESESIIHDRH

FLG2

1526

Q5D862
SQHGESESIVDERHG

FLG2

1831

Q5D862
QLLTSLHHFVGEGES

MDN1

3196

Q9NU22
RFERSESDGQLFEHH

KCTD7

211

Q96MP8
HLEAQEDSRGHTLAF

MAGEL2

891

Q9UJ55
EVQHERGASGGQTFH

INTS1

1291

Q8N201
ENYASGSDHLGSHER

LRRC7

966

Q96NW7
GTHSFEGLHNLETLD

LGR6

226

Q9HBX8
NESLSSDERHGHGPS

GABRQ

501

Q9UN88
DGSLHLDRALQEHAG

HMCN2

936

Q8NDA2
LTAAGESSHGNEREF

IL12RB2

601

Q99665
NTHGLRIYLESEHGS

BCL11A

191

Q9H165
HHSAQELAGSRIGAF

HMGCS2

396

P54868
LENSSELHRAGGDLH

MGAT5B

91

Q3V5L5
THLGGEDFDNRLVNH

HSPA1B

226

P0DMV9
RFSGIDEHGHLTIDT

NID1

536

P14543
RATGHGEHFSAQELA

ENDOU

211

P21128
ISHSASGGLDNETHF

FRYL

996

O94915
GLRTTEEALHASHGF

NDUFA13

126

Q9P0J0
VGTHREDSVSLNGNH

TCF12

466

Q99081
QLQHGLTLEFEHSDS

INTS2

121

Q9H0H0
VIGHEITHGFDDNGR

MME

581

P08473
GLHELVRHYTNASDG

LCK

201

P06239
ASNIDDVLGHHTGFL

TUBGCP2

716

Q9BSJ2
AGDHTRLEFHNIETG

NRXN1

836

Q9ULB1
IGHEITHGFDDNGRN

MMEL1

611

Q495T6
ENIVHGSGSQLFDHV

HK1

116

P19367
EGSHRAHSLLFENSD

PHACTR4

436

Q8IZ21
GKDHVVSDFSEHGSL

ALDH18A1

766

P54886
ALRGELQSSDLFHHS

PLOD1

461

Q02809
QEDEAHHIISGGRFL

HMCN1

2521

Q96RW7
HETGDSGRFSHESND

PRTG

1121

Q2VWP7
SGRFSHESNDEIHLS

PRTG

1126

Q2VWP7
QISGLHGNSFHSEDE

FLT3

751

P36888
HSTEGDILELVDGHF

ENOPH1

166

Q9UHY7
LAREQHAGTSEGLHL

FBF1

436

Q8TES7
DFAVHGESLGDRHLR

ENTR1

251

Q96C92
STTELDFEAGHRSFH

CDHR3

191

Q6ZTQ4
GDVDAHSTHGRSNFR

FNDC3A

161

Q9Y2H6
SHSFHIEPSGDLVNR

CCDC73

866

Q6ZRK6
DGRGDHQLSHYSLAE

GGT5

366

P36269
VGRREGLHSSDHFQA

C1QTNF8

121

P60827
GTHCTFGDDRHLTNR

HAS1

331

Q92839
DGSEELAHGHSSQSL

KIAA1210

791

Q9ULL0
IHSLEDGGQDGASRH

CLPB

211

Q9H078
THLGGEDFDNRLVNH

HSPA1A

226

P0DMV8
EHGERGSFAETDEHT

FAM9C

46

Q8IZT9
FLTEHRDGFQHGELG

EBP

166

Q15125
IRLHFGSEDSQGSEH

CA10

131

Q9NS85
LIGHHGAEDATDAFR

FADS3

61

Q9Y5Q0
STNHGLEIDESVNGH

SLC13A1

176

Q9BZW2
SSLFEHIGQHQFGED

RYR2

3106

Q92736
FNDTLRLIGEHHDGV

KIR2DL1

66

P43626
TEQFTGDHTQHFLDG

DYRK3

66

O43781
DSDGSHDLIGTFHTS

CPNE1

216

Q99829
SIKDRHESVGHGEDF

MED1

581

Q15648
HESVGHGEDFSKVSQ

MED1

586

Q15648
EEHIEGGHSNTDRPS

IL4I1

366

Q96RQ9
FNDTLRLIGEHHDGV

KIR2DS1

66

Q14954
DGFRTHDLTLASHEE

RTKN

271

Q9BST9
EDRTRAHADHVGQGF

RSBN1

576

Q5VWQ0
DRTRAHADHIGQGFE

RSBN1L

566

Q6PCB5
HADHIGQGFERQTTA

RSBN1L

571

Q6PCB5
THARLHSLEETFGCG

RARS2

466

Q5T160
HQHVFDDLRGSVSLS

SORT1

101

Q99523
HLEVHREGDGSSTTD

PHTF2

211

Q8N3S3
TGLHTGHSFQIVRDD

TPSD1

201

Q9BZJ3
GTRHGVDTHLFSVES

SNTA1

371

Q13424
TRFHTRGVNDDGHVS

SYNJ2

216

O15056
FRNHGELSHEQETLS

FER1L5

951

A0AVI2
HSGDFSVHVTNDDRG

KCP

1246

Q6ZWJ8
NARGFGRHSHDEISI

FAM20A

431

Q96MK3
NTAERSHRGEGEEDH

RNF146

256

Q9NTX7
SVGHDGSHALLVAED

MYCBP2

586

O75592
NSEHRSHSTGFIEGV

NUAK1

406

O60285
DSNTHRHLTEFVGLD

DARS1

276

P14868
FVDRTLDLTGAVGHH

SCFD2

271

Q8WU76
HDTESPHLRFSDADG

RNF220

146

Q5VTB9
IATAGDRTEEFHGHA

RIC8A

261

Q9NPQ8
DRTEEFHGHAVNLLG

RIC8A

266

Q9NPQ8
GFERQHSLPSSEHLG

NCKIPSD

141

Q9NZQ3
NDLEDVGRDLSHHTF

AARS2

116

Q5JTZ9
DSDGHGNHRESSPFL

SLC12A4

36

Q9UP95
SAEDFDHHGRVSLGS

SLX4IP

301

Q5VYV7
HGTEDEVIDFSHGLA

ABHD17B

231

Q5VST6
ELAHRAFFHGGDSDS

ADPRH

291

P54922
TRDQFLDTLQAHGHD

NCAPD2

361

Q15021
RDQDFHSGTFGGILH

CNDP1

256

Q96KN2
LGAFVIDSDHLGHRA

COASY

381

Q13057
ETFTTRHGEVGSALH

C10orf62

76

Q5T681
RHGEVGSALHRESFT

C10orf62

81

Q5T681
THTFNSGEARPGDRH

SEMA6B

846

Q9H3T3
EDGNTALHFAAREGH

TRPA1

546

O75762
DISNFGAHQRTHRGE

ZNF691

266

Q5VV52
STENGFHSVGHELAD

TIAM2

111

Q8IVF5
NFTSAGDHIIIDGLH

MIPEP

241

Q99797
LTFFDELHNVGRDHG

MIS12

156

Q9H081
ELHNVGRDHGTSDFR

MIS12

161

Q9H081
LSRDHHDVSGTDSPF

UROC1

541

Q96N76
HTLRLGVEVDSFDGH

PATJ

566

Q8NI35
IAEEHGLRHDSSGEG

IGHMBP2

761

P38935
LEFSHSDSRDQVIGH

SUGP2

111

Q8IX01
DAESLERHGLTHGAG

ZNF646

586

O15015
STQGFHVDHTAELRG

TMPRSS9

51

Q7Z410
HTHFQEQSVGERGAA

ZBED10P

31

Q96FA7
HSRFLQGHEKTHTGE

ZNF799

571

Q96GE5
TFGVESSLRAAGHHS

PHOSPHO1

126

Q8TCT1
GENETLSGRDIEHHL

STAB2

2366

Q8WWQ8
DDGTADFHSSGHIVV

PREX2

311

Q70Z35
TREGHHLVASGSEDG

WDR6

991

Q9NNW5
TGTLQRHESHHTGDF

ZNF813

71

Q6ZN06
ISEHVENAGVHSGDA

CAD

1151

P27708
EGGHVHTSDDSEVVF

SETD2

986

Q9BYW2
HDGTIEFTSIDAHNG

VRK1

221

Q99986
DEFSEGLRHSAHLNR

ZNF229

296

Q9UJW7
FESDHLGSGSHFSNR

UACA

376

Q9BZF9
GQRTSADTHGALDDH

ATP6V0A4

696

Q9HBG4
HDELISKSFQGSHGR

YPEL4

41

Q96NS1
TFGASRHHSAGDVAE

ZIC1

16

Q15915
NNGTRAEFILDSTHH

VPS13B

506

Q7Z7G8
SSSDLVRHQGVHTGE

ZNF213

356

O14771
GDGDIFTHLNSHTEV

ZNF484

206

Q5JVG2
TGTLQRQASHHIGDF

ZNF28

71

P17035
FHSLDRNQDGHIDVS

SLC25A23

86

Q9BV35
FLHLGEHDGSLDLRS

TMC5

981

Q6UXY8
TGTLERHESHHIGDF

ZNF860

86

A6NHJ4
DAGELAQHSRVHSGE

ZNF581

156

Q9P0T4
SQSFVAVHHSEEGRD

PJA2

116

O43164
AVHHSEEGRDTLGSS

PJA2

121

O43164
SHGGQDLSADAFHRL

TFIP11

466

Q9UBB9
ESHQHGSEEREEGSQ

TYW1B

216

Q6NUM6
LGRHEAGASSSDHQD

UBR5

1001

O95071
GEDFSHITDFTDHQR

ZFP90

456

Q8TF47
RLHNGGDVTFHDVLS

NALCN

1521

Q8IZF0